Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma

NCT07136519 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma (NPC)

Interventions

DRUG: Toripalimab
DIETARY_SUPPLEMENT: Omega-3
RADIATION: radiotherapy
DRUG: Paclitaxel (albumin bound)
DRUG: Cisplatin

Sponsor

Affiliated Hospital of Guangdong Medical University